Advan Six Inc. ASIX
We take great care to ensure that the data presented and summarized in this overview for AdvanSix Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ASIX
View all-
Black Rock Inc. New York, NY4.79MShares$107 Million0.0% of portfolio
-
Victory Capital Management Inc2.41MShares$53.6 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$44.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.57MShares$34.9 Million0.01% of portfolio
-
State Street Corp Boston, MA1.05MShares$23.4 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.04MShares$23.1 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO824KShares$18.3 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA712KShares$15.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA621KShares$13.8 Million0.0% of portfolio
-
Lsv Asset Management Chicago, IL601KShares$13.4 Million0.03% of portfolio
Latest Institutional Activity in ASIX
Top Purchases
Top Sells
About ASIX
AdvanSix Inc. manufactures and sells polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, alpha-methyl styrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. It offers its products under the Aegis, Capra, Sulf-N, Nadone, Naxol, and EZ-Blox brands. The company sells its products directly, as well as through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.
Insider Transactions at ASIX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 02
2025
|
Achilles B. Kintiroglou SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
571
-1.75%
|
$13,704
$24.85 P/Share
|
|
Jun 30
2025
|
Patrick Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
552
+1.59%
|
$12,696
$23.75 P/Share
|
|
Jun 30
2025
|
Donald P Newman Director |
BUY
Grant, award, or other acquisition
|
Direct |
977
+7.51%
|
$22,471
$23.75 P/Share
|
|
Jun 18
2025
|
Patrick Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,020
+12.98%
|
-
|
|
Jun 18
2025
|
Daniel F Sansone Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,020
+12.15%
|
-
|
|
Jun 18
2025
|
Sharon Spurlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,020
+6.29%
|
-
|
|
Jun 18
2025
|
Donald P Newman Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,020
+31.24%
|
-
|
|
Jun 18
2025
|
Gena C Lovett Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,020
+24.87%
|
-
|
|
Jun 18
2025
|
Todd D. Karran Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,020
+5.53%
|
-
|
|
Jun 02
2025
|
Achilles B. Kintiroglou SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
571
-1.72%
|
$13,133
$23.65 P/Share
|
|
May 01
2025
|
Achilles B. Kintiroglou SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
3,237
-8.9%
|
$67,977
$21.34 P/Share
|
|
Apr 01
2025
|
Achilles B. Kintiroglou SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
4,000
-9.91%
|
$88,000
$22.24 P/Share
|
|
Mar 31
2025
|
Donald P Newman Director |
BUY
Grant, award, or other acquisition
|
Direct |
993
+14.15%
|
$21,846
$22.65 P/Share
|
|
Mar 31
2025
|
Patrick Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
579
+1.99%
|
$12,738
$22.65 P/Share
|
|
Mar 24
2025
|
Rachael E Ryan VP, Controller |
BUY
Grant, award, or other acquisition
|
Direct |
12,966
+37.5%
|
-
|
|
Mar 03
2025
|
Achilles B. Kintiroglou SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
4,000
-9.02%
|
$108,000
$27.75 P/Share
|
|
Feb 28
2025
|
Christopher Gramm Controller |
BUY
Grant, award, or other acquisition
|
Direct |
12,992
+11.11%
|
-
|
|
Feb 28
2025
|
Christopher Gramm Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
1,934
-4.45%
|
$52,218
$27.75 P/Share
|
|
Feb 28
2025
|
Kelly Slieter SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,073
+20.11%
|
-
|
|
Feb 28
2025
|
Kelly Slieter SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,319
-8.46%
|
$89,613
$27.75 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 197K shares |
|---|---|
| Exercise of conversion of derivative security | 10.4K shares |
| Open market or private purchase | 5.03K shares |
| Payment of exercise price or tax liability | 32.2K shares |
|---|---|
| Open market or private sale | 74.2K shares |